Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Celsentri“
Suchtreffer
Begriffe & Kennungen
Celsentri · 4.5 · 9 Indinavir Limited data are available for co- administration with indinavir. Indinavir is a potent CYP3A4 inh
Eintrag öffnenCelsentri · 4.5 · Based on the in vitro and clinical data, the potential for maraviroc to affect the pharmacokinetics of co-admi
Eintrag öffnenCelsentri · 4.5 · Based on the in vitro and clinical data, the potential for maraviroc to affect the pharmacokinetics of co-admi
Eintrag öffnenCelsentri · 4.5 · Concomitant use of CELSENTRI and fosamprenavir/ritonavir is not recommended. Clarithromycin, Not studied, but
Eintrag öffnenCelsentri · 4.5 · Fosamprenavir/ritonavir Maraviroc AUC12: ↑ 2.49 Concomitant use is not 700 mg/100 mg BID Maraviroc Cmax: ↑ 1.5
Eintrag öffnenCelsentri · 4.5 · Maraviroc is a metabolised by cytochrome P450 CYP3A4 and CYP3A5. Co-administration of maraviroc with medicinal
Eintrag öffnenCelsentri · 4.5 · Maraviroc is a substrate for the transporters P-glycoprotein and OATP1B1, but the effect of these transporters
Eintrag öffnenCelsentri · 4.5 · Maraviroc is a substrate for the transporters P-glycoprotein and OATP1B1, but the effect of these transporters
Eintrag öffnenCelsentri · 4.5 · Maraviroc is metabolised by cytochrome P450 CYP3A4 and CYP3A5. Co-administration of maraviroc with medicinal p
Eintrag öffnenCelsentri · 4.5 · Medicinal product by Effects on active substance levels Recommendations therapeutic areas Geometric mean chang
Eintrag öffnenCelsentri · 4.5 · Medicinal product by Effects on active substance levels Recommendations therapeutic areas Geometric mean chang
Eintrag öffnenCelsentri · 4.5 · NNRTI + PI Efavirenz 600 mg QD + Maraviroc AUC12: ↑ 2.53 CELSENTRI dose should be lopinavir/ritonavir Maraviro
Eintrag öffnenCelsentri · 4.5 · NNRTI + PI Efavirenz 600 mg QD + Maraviroc AUC12: ↑ 2.53 CELSENTRI dose should lopinavir/ritonavir Maraviroc C
Eintrag öffnenCelsentri · 4.5 · Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) 35 Efavirenz 600 mg QD Maraviroc AUC12: ↓ 0.55 CELSEN
Eintrag öffnenCelsentri · 4.5 · Renal clearance accounts for approximately 23% of total clearance of maraviroc when maraviroc is administered
Eintrag öffnenCelsentri · 4.5 · Renal clearance accounts for approximately 23% of total clearance of maraviroc when maraviroc is administered
Eintrag öffnenCelsentri · 4.5 · Ritonavir AUC12: ↓ 0.66 Ritonavir Cmax: ↓ 0.61 Ritonavir C12: ↔ 0.86
Eintrag öffnenCelsentri · 4.5 · Ritonavir AUC12: ↓ 0.66 Ritonavir Cmax: ↓ 0.61 Ritonavir C12: ↔ 0.86
Eintrag öffnenCelsentri · 4.5 · Ritonavir AUC12: ↔ 0.93 Ritonavir Cmax: ↔ 1.02 Ritonavir C12: ↓ 0.74 Etravirine and Not studied. Based on the
Eintrag öffnenCelsentri · 4.5 · Ritonavir AUC12: ↔ 0.93 Ritonavir Cmax: ↔ 1.02 Ritonavir C12: ↓ 0.74 Etravirine and Not studied. Based on the
Eintrag öffnen